Healthcare Sales & Marketing Network News: LEVADEX

Searching News Database: LEVADEX

HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 22 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 9 Aug 2011
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2011
MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
Biopharmaceuticals

HSMN NewsFeed - 11 Jan 2010
MAP Pharmaceuticals Announces FDA will not Require a Second Pivotal Efficacy Study for LEVADEX(TM) NDA Submission
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 1 Dec 2009
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2009
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Biopharmaceuticals

HSMN NewsFeed - 26 May 2009
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
Biopharmaceuticals

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.